Some excessive bleedings in foetuses and neonates occur because there are too few blood platelets to stop the bleeding. This may be caused by Foetal Neonatal Alloimmune Thrombocytopenia (FNAIT).


is an EU-funded collaborative project aiming to develop a safe new treatment that prevents excessive bleeding in foetuses and newborns caused by FNAIT.


Plasma from women who have had a foetus/child with FNAIT is needed to produce the new drug that can prevent FNAIT. We strongly encourage these women to donate plasma for production of this drug.


The PROFNAIT consortium was represented by a booth in the exhibitor area and a poster at the scientific part of the SMFM 34th Annual Meeting-The Pregnancy Meeting in New Orleans in the USA, February 3-8.
We would like to thank Professor James Bussel at Weill Medical College of Cornell University for a great oral presentation at the conference, highlighting the PROFNAIT consortium (3 photos)
See MoreSee Less

9 months ago  ·  

View on Facebook